![Jonathan Biller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Biller
Treasurer bei
JUNO THERAPEUTICS INC
Vermögen: 7 Mio $ am 30.06.2026
Profil
Jonathan Prim Biller is currently Director at Acetylon Pharmaceuticals, Inc., Celgene UK Manufacturing (II) Ltd., Celgene UK Manufacturing Ltd., Celgene UK Holdings Ltd., and Celgene Europe Ltd. Mr. Biller is Treasurer at Juno Therapeutics, Inc. and Secretary at Alpine Immune Sciences, Inc. since 2024.
Former positions include Director at Junior Achievement of New Jersey, Inc., Director at Celgene Ltd. from 2012 to 2019, Executive Vice President & General Counsel at Celgene Corp.
from 2018 to 2019, Partner at Foley & Lardner LLP, Secretary, Chief Tax Officer & General Counsel at Bunge Ltd. from 2008 to 2011, CFO, Head-Legal & Corporate Affairs at Agios Pharmaceuticals, Inc. from 2020 to 2022, Partner at Hopkins & Sutter, and Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Brown University conferred in 1985 and a graduate degree from Yale Law School conferred in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.02.2026 | 13 659 ( 0,01 % ) | 7 Mio $ | 30.06.2026 |
Aktive Positionen von Jonathan Biller
| Unternehmen | Position | Beginn |
|---|---|---|
| JUNO THERAPEUTICS INC | Treasurer | - |
| ALPINE IMMUNE SCIENCES, INC. | Unternehmenssekretär | 20.05.2024 |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Direktor/Vorstandsmitglied | - |
Celgene UK Manufacturing Ltd.
 Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Celgene UK Manufacturing (II) Ltd.
 Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Celgene UK Holdings Ltd.
 Celgene UK Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Celgene Europe Ltd.
 Celgene Europe Ltd. BiotechnologyHealth Technology Engages in research and development in pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jonathan Biller
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 01.03.2026 |
| AGIOS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 16.09.2022 |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jonathan Biller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Foley & Lardner LLP
 Foley & Lardner LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Process Industries |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hopkins & Sutter
 Hopkins & Sutter Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Junior Achievement of New Jersey, Inc.
 Junior Achievement of New Jersey, Inc. Part of JA Worldwide, Inc., Junior Achievement of New Jersey, Inc. is a company based in Princeton, NJ. James W. Horne has been the CEO of the company since 2022. | |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Health Technology |
Celgene UK Manufacturing (II) Ltd.
Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Celgene UK Manufacturing Ltd.
Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Celgene UK Holdings Ltd.
Celgene UK Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Yale Law School
 Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Celgene Ltd.
 Celgene Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Engages in research and development in pharmaceutical products | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
